Join BIOCYTOGEN at CBA-GP Biomedical Science Symposium 2025
We’re proud to share that we’ll be exhibiting at the CBA-GP Biomedical Science Symposium 2025! Scheduled for February 8th in Philadelphia, this prestigious event offers an invaluable stage for biotech companies to highlight their cutting-edge innovations. Providing unique opportunities for direct connections with investors and industry leaders, the symposium encourages collaboration and paves the way for transformative progress in life sciences.
What is CBA-GP Biomedical Science Symposium 2025?
The Chinese Biopharmaceutical Association – Greater Philadelphia (CBA-GP) is a new chapter of Chinese Biopharmaceutical Association, USA (CBA) established in 2023. The CBA-GP is an independent, non-political, non-profit professional organization. The executive team of CBA-GP consists of academic professors (from institutions such as Temple, UPenn, Drexel, Villanova, Blumberg, Lehigh, Rutgers, Weill Cornell, UTMB), entrepreneurs (founders/CEOs), and industry executives (from biopharmaceutical companies such as Johnson & Johnson, Merck, GSK, BMS).
Event Overview
Date: February 8th 8:00 am – 5:15 pm
Venue: Connelly Center, Villanova University. 800 E Lancaster Ave, Villanova, PA 19085.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the CBA-GP Biomedical Science Symposium 2025 in Philadelphia!
